Dt. Malone et Da. Taylor, Involvement of somatodendritic 5-HT1A receptors in Delta(9)-tetrahydrocannabinol-induced hypothermia in the rat, PHARM BIO B, 69(3-4), 2001, pp. 595-601
Previously, it has been reported that modulating serotonergic neurones by u
se of selective serotonin reuptake inhibitors (SSRI) can alter the hypother
mic response produced by Delta (9)-tetrahydrocannabinol (Delta (9)-THC). Th
e aim of the present study was to investigate the effect that activation or
antagonism of 5-hydroxytryptamine (5-HTIA) receptors has on Delta (9)-THC-
induced hypothermia. Delta (9)-THC (0.5, 2 and 5 mg/kg iv) decreased body t
emperature in a dose-related manner. Whilst having no significant effect on
body temperature when administered 40 min prior to vehicle injection, the
5-HTIA receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N
-(2-pyridinyl) cyclohexane-carboxamide trihydrochloride (WAY 100635; 1 mg/k
g sc) significantly potentiated the hypothermia produced by 2 and 5 mg/kg D
elta (9)-THC. In order to investigate whether this effect was due to antago
nism at somatodendritic autoreceptors in midbrain raphe nuclei, WAY 100635
or the 5-HTIA agonist 8-hydroxy-(di-n-propylamino) tetralin (8-OH-DPAT) was
microinjected into either the median raphe nuclei (MRN) or dorsal raphe nu
clei (DRN) 40 min prior to Delta (9)-THC injection. Following microinjectio
n into the DRN, neither WAY 100635 (0.5 nmol/0.5 mul/10 s) nor 8-OH-DPAT (1
5.2 nmol/0.5 mul/10 s) had any significant effect on Delta (9)-THC-induced
hypothermia. However, WAY 100635 when microinjected into the MRN significan
tly potentiated Delta (9)-THC-induced hypothermia, and 8-OH-DPAT microinjec
ted into the MRN significantly inhibited Delta (9)-THC-induced hypothermia.
It is suggested from these studies that the potentiation of Delta (9)-THC-
induced hypothermia by WAY 100635 when administered peripherally is mainly
due to antagonism at somatodendritic 5-HTIA autoreceptors in the MRN. (C) 2
001 Elsevier Science Inc. All rights reserved.